ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,093Medicare Part D Prescriptions Filled, Including Refills

Rank: 17 out of 434

$546K Total Retail Price of All Prescriptions

Rank: 30 out of 434

801 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
19% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nevada
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 801 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

22% of this provider’s 801 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 12,297 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

15% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$36 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 13.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nevada
HYDROCODONE-ACETAMINOPHEN 938 735 S3 1 4
SIMVASTATIN 776 716 2 2
OMEPRAZOLE 744 634 3 5
LISINOPRIL 732 661 4 1
LEVOTHYROXINE SODIUM 669 587 5 3
FUROSEMIDE 453 413 6 9
METOPROLOL TARTRATE 339 301 7 12
GABAPENTIN 319 216 8 14
TERAZOSIN HCL 271 250 9 40
SERTRALINE HCL 234 181 10 27
FLUOXETINE HCL 228 191 11 32
AMLODIPINE BESYLATE 225 198 12 6
ZOLPIDEM TARTRATE 224 172 13 11
ALENDRONATE SODIUM 219 205 14 15
POTASSIUM CHLORIDE 215 182 15 20
METFORMIN HCL 210 184 16 7
METFORMIN HCL ER 199 191 17 48
LOVASTATIN 196 184 18 10
ATENOLOL 181 155 19 16
VENTOLIN HFA 174 138 20 30
TRIAMTERENE-HCTZ 172 162 21 47
WARFARIN SODIUM 170 151 22 18
PRAVASTATIN SODIUM 170 133 22 17
HYDROCHLOROTHIAZIDE 170 159 22 8
RANITIDINE HCL 159 123 25 31
MELOXICAM 150 126 26 46
OXYCODONE HCL 144 19 S2 27 34
MORPHINE SULFATE ER 139 46 S2 28 50
CLOPIDOGREL 138 125 29 41
CARISOPRODOL 128 34 R 30 44
LOSARTAN POTASSIUM 127 126 31 13
BUPROPION HCL SR 119 62 32 129
DONEPEZIL HCL 113 113 33 35
PREDNISONE 108 99 34 42
AMITRIPTYLINE HCL 106 89 R 35 57
METOPROLOL SUCCINATE 102 89 36 22
OXYCODONE HCL-ACETAMINOPHEN 100 54 S2 37 53
OXYCODONE-ACETAMINOPHEN 99 40 S2 38 74
ALLOPURINOL 99 85 38 25
DILTIAZEM 24HR ER 95 91 40 103
FINASTERIDE 94 81 41 54
CYCLOBENZAPRINE HCL 93 24 R 42 101
PLAVIX 91 81 43 64
CARVEDILOL 90 72 44 24
GLIPIZIDE 85 85 45 37
LANTUS 81 55 46 80
IBUPROFEN 76 71 47 56
GLIPIZIDE ER 75 68 48 65
DIGOXIN 69 53 49 69
BENAZEPRIL HCL 69 63 49 49
CITALOPRAM HBR 69 38 49 23
METHADONE HCL 69 38 S2 49 108
GLYBURIDE 68 66 R 53 51
LISINOPRIL-HYDROCHLOROTHIAZIDE 67 66 54 21
LANTUS SOLOSTAR 65 62 55 71
OXYBUTYNIN CHLORIDE 64 62 56 82
ENALAPRIL MALEATE 63 51 57 59
MECLIZINE HCL 62 47 58 159
PAROXETINE HCL 61 51 59 61
JANTOVEN 59 58 60 161
FLUTICASONE PROPIONATE 58 55 61 26
INSULIN SYRINGE 56 43 62 120
POLYETHYLENE GLYCOL 3350 56 45 62 81
HYDROMORPHONE HCL 56 11 S2 62 174
TAMSULOSIN HCL 55 43 65 29
SPIRONOLACTONE 51 35 66 70
PREMARIN 50 49 R 67 187
NAPROXEN 50 22 67 75
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 21, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.